Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Source: SEC Form 13F · as of Mar 2026

Connor, Clark & Lunn Investment Management Ltd. holds 73 biotech & pharma companies tracked by BioSniper, totaling $761.2M in value as of Mar 2026 (SEC Form 13F).

Companies held

73

Total value held

$761.2M

BioSniper AIPage evidence connected

Prepared research question

What matters most for GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)2,817,445$155.5M
SNYSanofi2,223,301$107.1M
IONSIONIS PHARMACEUTICALS INC874,089$65.6M
ARWRARROWHEAD PHARMACEUTICALS, INC.836,981$52.5M
KNSAKiniksa Pharmaceuticals International, plc649,629$31.3M
REGNREGENERON PHARMACEUTICALS, INC.32,164$24.9M
AXSMAxsome Therapeutics, Inc.134,792$22.8M
GILDGILEAD SCIENCES, INC.154,780$21.6M
TERNTerns Pharmaceuticals, Inc.384,681$20.3M
VKTXViking Therapeutics, Inc.516,108$16.8M
AGIOAGIOS PHARMACEUTICALS, INC.450,093$15.2M
TEVATeva Pharmaceutical Industries Limited471,891$14.2M
RYTMRHYTHM PHARMACEUTICALS, INC.151,842$13.2M
IMVTImmunovant, Inc.503,673$12.5M
FOLDAMICUS THERAPEUTICS, INC.747,465$10.8M
NTLAIntellia Therapeutics, Inc.748,636$9.6M
ADPTAdaptive Biotechnologies Corp649,627$9.0M
RVMDREVOLUTION MEDICINES, INC.91,720$8.9M
ANABANAPTYSBIO, INC158,562$8.8M
INSMINSMED Inc46,230$7.6M
ELVNEnliven Therapeutics, Inc.191,293$7.5M
TNGXTango Therapeutics, Inc.355,229$7.4M
NKTRNEKTAR THERAPEUTICS98,745$7.1M
ORICOric Pharmaceuticals, Inc.522,061$6.6M
ACADACADIA PHARMACEUTICALS INC294,265$6.6M
KURAKura Oncology, Inc.800,597$6.5M
RCUSArcus Biosciences, Inc.281,681$6.1M
CLDXCelldex Therapeutics, Inc.184,104$5.8M
RDYDR REDDYS LABORATORIES LTD382,976$5.3M
COGTCogent Biosciences, Inc.136,450$5.3M
TVTXTravere Therapeutics, Inc.176,390$5.2M
NUVBNuvation Bio Inc.1,207,771$5.2M
NUVLNuvalent, Inc.50,026$5.1M
PBYIPUMA BIOTECHNOLOGY, INC.782,798$5.0M
FLGTFulgent Genetics Inc.302,564$4.8M
CGEMCullinan Therapeutics, Inc.289,115$4.1M
PTGXProtagonist Therapeutics, Inc27,260$2.9M
KROSKeros Therapeutics, Inc.257,884$2.8M
HRMYHarmony Biosciences Holdings, Inc.101,110$2.8M
CMPXCompass Therapeutics, Inc.497,818$2.6M
JBIOJade Biosciences, Inc.169,051$2.4M
XERSXeris Biopharma Holdings, Inc.407,625$2.4M
BDTXBlack Diamond Therapeutics, Inc.1,058,397$2.3M
TECXTectonic Therapeutic, Inc.66,994$2.1M
ZNTLZentalis Pharmaceuticals, Inc.792,001$1.9M
PRTAPROTHENA CORP PUBLIC LTD CO156,551$1.5M
ARVNARVINAS, INC.131,974$1.4M
ZVRAZEVRA THERAPEUTICS, INC.145,222$1.4M
OLMAOlema Pharmaceuticals, Inc.70,711$1.1M
LGNDLigand Pharmaceuticals Incorporated4,943$987K
APGEApogee Therapeutics, Inc.11,481$966K
ZYMEZymeworks Inc.37,919$949K
CCCCC4 Therapeutics, Inc.277,183$729K
RGNXREGENXBIO Inc.85,248$714K
NRIXNurix Therapeutics, Inc.44,976$697K
SVRASavara Inc122,862$671K
AGENAGENUS INC198,502$663K
PLRXPLIANT THERAPEUTICS, INC.517,453$652K
ASMBASSEMBLY BIOSCIENCES, INC.21,761$604K
OPKOPKO HEALTH, INC.522,906$596K
FATEFATE THERAPEUTICS INC469,785$564K
ANNXAnnexon, Inc.92,707$514K
PLXProtalix BioTherapeutics, Inc.207,275$450K
PRLDPrelude Therapeutics Inc109,085$373K
LENZLENZ Therapeutics, Inc.37,314$341K
ANIPANI PHARMACEUTICALS INC4,225$325K
LRMRLarimar Therapeutics, Inc.69,087$311K
FLNAFilana Therapeutics Inc.136,931$231K
SIGASIGA TECHNOLOGIES INC36,064$193K
ORMPORAMED PHARMACEUTICALS INC.50,207$171K
ABUSArbutus Biopharma Corp25,859$116K
KLRSKalaris Therapeutics, Inc.13,655$79K
AVXLANAVEX LIFE SCIENCES CORP.19,655$60K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.